ClinicalTrials.gg
CompletedNCT07517783Updated Apr 8, 2026

"Comparison of Clip-Based and Clipless Laparoscopic Gallbladder Surgery in Controlling Bleeding"

An interventional study of clips and ligasure in Laparoscopic Cholecystectomy Surgery, sponsored by Wah Medical college , POF hospital. Completed at 1 site in Pakistan. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-04-08.

Sponsored by Wah Medical college , POF hospital · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 2 years 2 months after the study started (first participant enrolled Jan 2024, registered Mar 2026).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
114
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

This randomized clinical trial compared titanium clips and LigaSure (a vessel sealing device) for controlling bleeding during laparoscopic gallbladder surgery. A total of 114 patients were divided into two equal groups, with one group receiving clips and the other treated using LigaSure.

The study found that LigaSure significantly reduced intraoperative blood loss and the time required to achieve hemostasis compared to clips, while overall operative time remained similar in both groups. No major complications were observed.

The results suggest that LigaSure provides more efficient and reliable bleeding control, likely due to its advanced mechanism of sealing blood vessels. Although clips remain widely used, LigaSure may be a better option, especially in difficult surgical cases.

Overall, the study concludes that LigaSure is a safe and effective alternative to titanium clips with superior hemostatic outcomes in laparoscopic cholecystectomy.

Read the detailed description

This randomized clinical trial was conducted to compare the effectiveness of titanium clips and LigaSure, an advanced bipolar vessel sealing device, in achieving hemostasis during laparoscopic cholecystectomy. A total of 114 patients undergoing elective laparoscopic gallbladder surgery were enrolled and randomly assigned into two equal groups. In Group A, the cystic artery was ligated using conventional titanium clips, while in Group B, vessel sealing was performed using the LigaSure device without the use of clips. This study specifically focused on key intraoperative outcomes, including blood loss and the time required to achieve complete hemostasis.

The findings of the study demonstrated that patients in the LigaSure group experienced significantly lower intraoperative blood loss compared to those in the clip group. In addition, the time required to achieve hemostasis was markedly shorter in the LigaSure group, indicating faster and more efficient control of bleeding. Despite these advantages, the total operative time remained comparable between the two groups, suggesting that the use of LigaSure does not prolong the surgical procedure. Importantly, no major intraoperative or postoperative complications were reported in either group, confirming the safety of both techniques.

The improved performance of LigaSure in achieving hemostasis can be attributed to its mechanism of action, which involves the application of controlled bipolar energy to seal blood vessels by denaturing collagen and elastin within the vessel walls. This results in a permanent and reliable seal, minimizing the risk of bleeding. In contrast, titanium clips rely on mechanical occlusion, which may be associated with potential issues such as clip slippage or displacement, particularly in difficult surgical conditions.

These results suggest that LigaSure provides more efficient and consistent hemostatic control compared to conventional clips. This advantage is particularly relevant in complex cases, such as acute inflammation or dense adhesions, where precise and secure vessel sealing is crucial. Although titanium clips continue to be widely used due to their low cost and accessibility, LigaSure may offer superior outcomes in selected patients.

In conclusion, this study establishes that LigaSure is a safe, effective, and reliable alternative to titanium clips for cystic artery control in laparoscopic cholecystectomy. Its use is associated with reduced intraoperative blood loss and faster achievement of hemostasis, making it a valuable tool for improving surgical efficiency and patient outcomes.

02

Conditions studied

  • Laparoscopic Cholecystectomy Surgery

Keywords

  • Laparoscopic cholecystectomy, LigaSure
03

In context

Lead sponsor

Wah Medical college , POF hospital is the lead sponsor of 4 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    • Fully consented patients aged 18 to 60 years

      • With any indication of laparoscopic cholecystectomy

Exclusion criteria

Exclusion Criteria:

    • Who need conversion to open cholecystectomy per-operatively

      • With bleeding diathesis (inherited or acquired bleeding disorders)
      • Who need concomitant complicated procedure during surgery (e.g., Whipple procedure, or stoma formation)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
114 participants (actual)

Study arms

  • Experimental
    group A: clips

    Group A is the control arm where patients have the cystic artery sealed with titanium clips during laparoscopic gallbladder surgery, and their bleeding and time to achieve hemostasis are measured for comparison.

    Device: clips

  • Experimental
    group B: ligasure

    Group B is the intervention arm where patients have the cystic artery sealed using LigaSure, and their bleeding and time to achieve hemostasis are measured for comparison with the conventional clip group.

    Device: ligasure

Interventions

  • Deviceclips

    in group A titanium clips are used to seal the cystic artery

  • Deviceligasure

    in group B, ligasure high energy vessel sealing device is used to seal cystic artery

06

What researchers measure

Primary outcomes

  1. intraoperative blood loss

    The study primarily aimed to compare how much patients bleed during surgery and how fast bleeding is controlled using titanium clips versus LigaSure.

    Time frame: From surgical incision to completion of surgery

Secondary outcomes

  1. time to achieve hemostasis

    this study compares how much intraoperative time of surgery required to control bleeding and achieve hemostasis with titanium clips vs using ligasure

    Time frame: From onset of cystic artery bleeding to complete cessation of bleeding during surgery

  2. operative time

    this study compares duration of surgery using titanium clips vs using ligasure

    Time frame: From surgical incision to completion of surgery

07

Study locations

1 site
  • Wah Medical College, POF Hospital Wah cantt
    Wāh, Punjab Province 47040, Pakistan
08

References and documents

Individual participant data

Plan to share: Yes

Supporting information: Study protocol, Clinical study report

Time frame: 1 year after publication of article in journal

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2024 to primary completion in May 2024, 4 months.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 29, 2026
First posted
Apr 8, 2026
StartActual
Jan 1, 2024
Primary completionActual
May 28, 2024
CompletionActual
Jun 30, 2024
Last update
Apr 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07517783
Lead sponsor
Wah Medical college , POF hospital
Responsible party
Sponsor
First posted
Apr 8, 2026
Start date
Jan 1, 2024
Primary completion
May 28, 2024
Completion
Jun 30, 2024
Last update
Apr 8, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion